Founder & CEO at Loyal

Taking the first dog lifespan drug through the FDA

We won what are believed to be the first FDA acceptances that a drug could work for lifespan extension.

Talk to me about
Chief of Staff at The Longevity Fund·2018 – 2020

Worked on human aging in venture, then went dogs first

As Laura Deming's chief of staff, I kept hitting walls on approving an aging drug. Dogs looked like the faster path.

Talk to me about
Sweden

Spent a year in Sweden at 21 and almost didn't leave

I studied nanobiotechnology at Uppsala and worked behind a bar. The whole group came to see me off.

Talk to me about
DPhil in Paediatrics (incomplete) at University of Oxford·2017 – 2019

Flew back and forth to avoid dropping out of Oxford

I'm a child of immigrants and my mom told everyone I was at Oxford. I left about six months short of my doctorate.

Talk to me about
Researcher: Neuro-oncology at Sanford Burnham Prebys·2015 – 2016

Tried to replace Parkinson's neurons, then chose prevention

Every little thing had to go right for a patient to get even a little benefit. That's how I landed on aging.

Talk to me about
Author at How to Build a Biotech

Wrote a guide for anyone curious about starting a biotech

It covers raising SF-style venture money, picking a drug type, and the trials you need before you can sell.

Talk to me about
Early life

Grew up in Austin with 15 cats and rescued squirrels

We rescued animals all the time and I wanted to be a vet. I never thought I'd end up working on dog drugs.

Talk to me about
Celine Halioua

Celine Halioua⁠

Loyal

Founder & CEO at Loyal

About

I'm founder and CEO of Loyal, a biotech developing drugs to extend dog lifespan.

Experiences

  1. Founder & CEO at LoyalTaking the first dog lifespan drug through the FDA

    We won what are believed to be the first FDA acceptances that a drug could work for lifespan extension.

  2. Chief of Staff at The Longevity FundWorked on human aging in venture, then went dogs first

    As Laura Deming's chief of staff, I kept hitting walls on approving an aging drug. Dogs looked like the faster path.

  3. SwedenSpent a year in Sweden at 21 and almost didn't leave

    I studied nanobiotechnology at Uppsala and worked behind a bar. The whole group came to see me off.

  4. DPhil in Paediatrics (incomplete) at University of OxfordFlew back and forth to avoid dropping out of Oxford

    I'm a child of immigrants and my mom told everyone I was at Oxford. I left about six months short of my doctorate.

  5. Researcher: Neuro-oncology at Sanford Burnham PrebysTried to replace Parkinson's neurons, then chose prevention

    Every little thing had to go right for a patient to get even a little benefit. That's how I landed on aging.

  6. Author at How to Build a BiotechWrote a guide for anyone curious about starting a biotech

    It covers raising SF-style venture money, picking a drug type, and the trials you need before you can sell.

  7. Early lifeGrew up in Austin with 15 cats and rescued squirrels

    We rescued animals all the time and I wanted to be a vet. I never thought I'd end up working on dog drugs.

Follow Celine for more...

XInstagramLinkedInWebsiteWebsite

© 2026 Delphi · Terms · Privacy

Celine Halioua

Celine Halioua⁠

Loyal

Founder & CEO at Loyal

About

I'm founder and CEO of Loyal, a biotech developing drugs to extend dog lifespan.

Experiences

  1. Founder & CEO at LoyalTaking the first dog lifespan drug through the FDA

    We won what are believed to be the first FDA acceptances that a drug could work for lifespan extension.

  2. Chief of Staff at The Longevity FundWorked on human aging in venture, then went dogs first

    As Laura Deming's chief of staff, I kept hitting walls on approving an aging drug. Dogs looked like the faster path.

  3. SwedenSpent a year in Sweden at 21 and almost didn't leave

    I studied nanobiotechnology at Uppsala and worked behind a bar. The whole group came to see me off.

  4. DPhil in Paediatrics (incomplete) at University of OxfordFlew back and forth to avoid dropping out of Oxford

    I'm a child of immigrants and my mom told everyone I was at Oxford. I left about six months short of my doctorate.

  5. Researcher: Neuro-oncology at Sanford Burnham PrebysTried to replace Parkinson's neurons, then chose prevention

    Every little thing had to go right for a patient to get even a little benefit. That's how I landed on aging.

  6. Author at How to Build a BiotechWrote a guide for anyone curious about starting a biotech

    It covers raising SF-style venture money, picking a drug type, and the trials you need before you can sell.

  7. Early lifeGrew up in Austin with 15 cats and rescued squirrels

    We rescued animals all the time and I wanted to be a vet. I never thought I'd end up working on dog drugs.

Follow Celine for more...

XInstagramLinkedInWebsiteWebsite

© 2026 Delphi · Terms · Privacy

By using this service, you agree to the Terms of Service and Privacy Policy.